DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells

Journal Article · · Analytical Cellular Pathology

Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin’s efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action.

Sponsoring Organization:
USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
OSTI ID:
1457218
Journal Information:
Analytical Cellular Pathology, Journal Name: Analytical Cellular Pathology Vol. 2018; ISSN 2210-7177
Publisher:
Hindawi Publishing CorporationCopyright Statement
Country of Publication:
Country unknown/Code not available
Language:
English

References (49)

Glioblastoma and Other Malignant Gliomas: A Clinical Review journal November 2013
New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent book October 2013
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis journal April 2007
Metformin: clinical use in type 2 diabetes journal August 2017
The mechanisms of action of metformin journal August 2017
Rho GTPases in primary brain tumor malignancy and invasion journal April 2012
Metformin use improves the survival of diabetic combined small-cell lung cancer patients journal May 2015
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications journal April 2017
Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions journal August 2013
Emerging role of plexins signaling in glioma progression and therapy journal February 2018
Hallmarks of Cancer: The Next Generation journal March 2011
Signaling networks of Rho GTPases in cell motility journal October 2013
Podosome-type adhesions and focal adhesions, so alike yet so different journal September 2008
Regulation of cell adhesion and migration by cell-derived matrices journal October 2013
Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I journal January 2000
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2 journal April 2016
American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 journal December 2015
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013 journal October 2016
Metformin inhibits glioma cell U251 invasion by downregulation of fibulin-3 journal January 2013
Cancer stem cells in glioblastoma journal June 2015
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner journal October 2009
Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer journal January 2014
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells journal October 2006
Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer journal March 2014
Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner journal June 2013
Glucose-6–phosphatase Is a Key Metabolic Regulator of Glioblastoma Invasion journal July 2014
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state journal July 2010
Metformin: an old but still the best treatment for type 2 diabetes journal February 2013
Exploring the role of metformin in anticancer treatments: A systematic review journal January 2014
Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action journal May 2013
Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer journal January 2014
Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response journal April 2015
Anticancer effects of metformin on neuroendocrine tumor cells in vitro [Anticancer effects of metformin on neuroendocrine tumor cells in vitro] journal July 2014
Metformin enhanced in vitro radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5’-monophosphate-activated protein kinase levels in glioblastoma journal November 2017
Metformin treatment reduces temozolomide resistance of glioblastoma cells journal October 2016
Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells journal August 2015
Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo journal September 2015
Invadopodia, Regulation, and Assembly in Cancer Cell Invasion journal June 2014
Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells journal November 2015
Effect of metformin on the human T98G glioblastoma multiforme cell line journal March 2014
StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion journal March 2014
Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion journal September 2014
Metformin inhibits leptin-induced growth and migration of glioblastoma cells journal August 2012
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells journal March 2016
Metformin inhibits the development and metastasis of ovarian cancer journal June 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt journal January 2013
Metformin — a new old drug journal August 2017
Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK journal November 2012
Cisplatin Combined with Metformin Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Regulating E-cadherin and MMP-9 journal May 2014

Related Subjects